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The Natural History of Pancreatitis-Induced Splenic
Vein Thrombosis
T. Ryan Heider, MD,* Samreen Azeem, MD,* Joseph A. Galanko, PhD,† and Kevin E. Behrns, MD*†
Objective: To determine the natural history of pancreatitis-induced
splenic vein thrombosis with particular attention to the risk of gastric
variceal hemorrhage.
Summary Background Data: Previous studies have suggested that
splenic vein thrombosis results in a high likelihood of gastric
variceal bleeding and that splenectomy should be performed to
prevent hemorrhage. Recent improvements in cross-sectional imag-
ing have led to the identification of splenic vein thrombosis in
patients with minimal symptoms. Our clinical experience suggested
that gastric variceal bleeding in these patients was uncommon.
Methods: A computerized index search from 1993 to 2002 for the
medical records of patients with a diagnosis of pancreatitis was
performed. Fifty-three patients with a diagnosis of pancreatitis and
splenic vein thrombosis were identified. The medical records of
these patients were reviewed, and follow-up was completed, includ-
ing the European Organization for Research and Treatment of
Cancer Quality of Life Questionnaire (EORTC-QLQ).
Results: Gastrosplenic varices were identified in 41 patients (77%)
with varices evident on computed tomography (CT) in 40 of 53
patients, on esophagogastroduodenoscopy (EGD) in 11 of 36 pa-
tients, and on both CT and EGD in 10 of 36 patients. This risk of
variceal bleeding was 5% for patients with CT-identified varices and
18% for EGD-identified varices. Overall, only 2 patients (4%) had
gastric variceal bleeding and required splenectomy. Functional qual-
ity of life was better than historical controls surgically treated for
chronic pancreatitis.
Conclusion: Gastric variceal bleeding from pancreatitis-induced
splenic vein thrombosis occurs in only 4% of patients; therefore,
routine splenectomy is not recommended.
(Ann Surg 2004;239: 876–882)
Though first recognized over 80 years ago as a cause ofgastrointestinal hemorrhage,1 the natural history of pan-
creatitis-induced splenic vein thrombosis with subsequent
gastric variceal bleeding remains poorly defined. Historically,
45% to 72% of patients with splenic vein thrombosis pre-
sented with gastric variceal bleeding,2 and the overwhelming
majority of these patients underwent splenectomy. The re-
ported frequency of splenic vein thrombosis, however, has
increased recently due to significant advances in cross-sec-
tional diagnostic imaging. In the remote past, splenic vein
thrombosis was recognized only on postmortem examina-
tion,1 but studies such as celiac angiography and splenopor-
tography have proved useful as diagnostic imaging has
evolved. Increasingly sensitive, noninvasive studies such as
computed tomography (CT), magnetic resonance imaging
(MRI), and ultrasound (US) are currently obtained frequently
in the evaluation of patients with acute or chronic pancreati-
tis, and splenic vein thrombosis is identified. Splenic vein
thrombosis complicates pancreatitis or pancreatic pseudo-
cysts in 7 to 20% of patients, and it is not infrequently
diagnosed as patients’ symptoms are resolving.3,4 Because
splenic vein thrombosis is more readily detected with im-
proved imaging and early gastric variceal bleeding is uncom-
mon, an opportunity to document the natural history of this
disease has arisen.
Previous studies cited the frequency of gastric variceal
hemorrhage as the critical event determining the manage-
ment, either observation3,5 or splenectomy.2,3,6–8 An accurate
assessment of the incidence of pancreatitis-induced splenic
vein thrombosis and the frequency of gastric variceal hem-
orrhage, however, has been limited by several factors. First,
the inclusion of pancreatic malignancies and extrapancreatic
etiologies as a cause of splenic vein thrombosis and gastric
variceal bleeding confounded the diagnosis and limited our
ability to determine the long-term risks. In addition, the lack
of a reliable diagnostic imaging modality impaired early
diagnosis and follow-up examination. Therefore, our aim was
to determine the natural history of pancreatitis-induced
splenic vein thrombosis with specific attention to the devel-
opment of gastric variceal hemorrhage. We found that only
4% of patients with pancreatitis-induced splenic vein throm-
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bosis developed clinically evident, gastric variceal bleeding
during follow-up.
METHODS
This study was reviewed and approved by the Univer-
sity of North Carolina Chapel Hill Committee on the Protec-
tion of the Rights of Human Subjects.
A computerized search for all patients with a diagnosis
of acute pancreatitis, chronic pancreatitis, or pancreatic
pseudocyst from 1993 to 2002 was performed. Documenta-
tion of splenic vein thrombus or venous-phase nonopacifica-
tion on CT or MRI was considered evidence of splenic vein
thrombosis. Fifty-three patients (39 male; mean age, 46  1.8
years) with clinical, laboratory, or radiographic evidence of
pancreatitis and radiographically-confirmed splenic vein
thrombosis were identified. Patients with evidence of cirrho-
sis, malignancy, or hypercoagulable states were excluded.
The medical records were reviewed in detail, and patient
demographics, clinical presentation, laboratory data, imaging
studies, procedures, and hospital course were recorded. Fol-
low-up data were obtained by standardized telephone inter-
view and administration of the European Organization for
Research and Treatment of Cancer Quality of Life Question-
naire (EORTC-QLQ) or from the last recorded clinical eval-
uation. The EORTC-QLQ has been used previously to assess
functional outcome in patients with pancreatic disease,9–11
and it permits functional and symptom scale assessment.
Functional evaluation includes assessment of physical status,
working ability, cognitive function, emotional well-being,
social well-being, and global quality of life. Symptom eval-
uation includes fatigue, nausea and vomiting, pain, loss of
appetite, dyspnea, sleep disturbance, constipation, diarrhea,
and financial strain. All survey scores were linearly trans-
formed to a 100-point scale for comparative purposes, and
higher scores represent improved functional status.
Data Analysis
Data are reported as the mean  SEM, or, where
appropriate, median values with the range are shown. Com-




Fifty-three patients had splenic vein thrombosis sec-
ondary to pancreatitis or the presence of a pseudocyst. The
mean age at diagnosis was 46  1.8 years, and 39 patients
(74%) were male. Splenic vein thrombosis was due to acute
pancreatitis in 13 patients (25%) and secondary to chronic
pancreatitis in the remaining 40 patients (75%). Pancreatitis
was most commonly caused by alcohol use, followed by
gallstones, idiopathic pancreatitis, hyperlipidemia, and pan-
creas divisum (Table 1).
Diagnostic Evaluation
CT was performed in all patients and demonstrated
splenic vein thrombosis in 22 (42%) and splenic vein non-
opacification in 31 (58%). Thrombosis was limited to the
splenic vein in 34 patients (64%), but it also involved the
superior mesenteric vein, portal vein, or both in 10 (19%), 3
(6%), and 6 (11%) patients, respectively. In addition to
splenic vein thrombosis, CT demonstrated gastrosplenic var-
ices in 40 patients (75%), and nearly 90% of all patients had
pancreatic pseudocysts (Tables 2 and 3). Ultrasound, MRI,
and angiography were performed in addition to CT and
confirmed splenic vein thrombosis in 7 (13%), 6 (11%), and
3 (6%) patients, respectively.
Esophagogastroduodenoscopy (EGD) was performed
in 36 (68%) of the 53 patients, and gastric varices were
documented in 11 patients (31%) (Table 3). A single patient
had varices on an EGD, but not on CT. Even though varices
were present in 75% of patients undergoing CT, only 2 of
these patients (5%) had variceal bleeding (Table 3). The rate
of bleeding was higher in patients who had varices on EGD
with 2 (18%) of 11 patients experiencing variceal bleeding.
The presence of varices on both CT and EGD did not predict
a higher rate of bleeding than EGD alone.
Clinical Course
Twenty-six patients (49%) were observed without in-
tervention, 6 patients (11%) underwent percutaneous pseudo-
cyst drainage, and 21 (40%) had operative procedures (Table
4). Importantly, intervention was not necessarily temporally
or causally related to the diagnosis of splenic vein thrombo-
sis. Five patients in the study population underwent splenec-
tomy, however, only 2 were related to gastric variceal bleed-
ing (Table 4). The first patient developed splenic vein
TABLE 1. Patient Demographics
n (%)
Number of patients 53
Mean age (yr) 45.5  1.8









Pancreas Divisum 1 (1.9)
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thrombosis secondary to chronic alcoholic pancreatitis and
required a splenectomy 5 months later for a non–life-threat-
ening gastric variceal bleed. The second patient had splenic
and SMV thrombosis secondary to alcoholic pancreatitis and
in the face of excessive anticoagulation developed gastric
variceal bleeding 2 months after diagnosis. Both patients’
varices were documented by EGD and CT and were success-
fully treated by splenectomy without further episodes of
bleeding. The remaining 3 patients underwent splenectomy
during operative treatment of pancreatic pseudocysts compli-
cated by splenic parenchymal involvement (2 patients) or
treatment of a refractory distal pancreatic fistula (1 patient).
Additionally, 3 episodes of nonvariceal upper gastroin-
testinal hemorrhage caused by a gastric ulcer, gastric cancer,
and gastritis occurred in the study population (Table 5). The
clinical picture of hypersplenism was noted in only 1 patient,
though nearly two thirds of patients manifested abnormal
platelet counts with thrombocytopenia and thrombocytosis
occurring in 10 (19%) and 22 (42%) patients, respectively. Of
the 7 (13%) deaths in the series, none were related to variceal
bleeding or the result of an operative complication (Table 5).
Follow-up
The mean length of follow-up for the entire cohort was
40.3  4.9 months (median, 34 months). The mean length of
follow-up for the 29 (63%) of 46 of evaluable patients who
were interviewed and completed the EORTC-QLQ survey
was 58.5  3.9 months. None of the interviewed patients
reported further hospitalization or treatment of upper gastro-
intestinal hemorrhage or reported signs and symptoms con-
sistent with occult intestinal bleeding. Median values for the
6 core functional scales did not differ from previous re-
ports9–11 of patients with chronic pancreatitis completing the
survey (Table 6). Likewise, symptom scale scores suggest
that pancreatitis complicated by splenic vein thrombosis does
not result in disabling symptoms; in fact, most patients have
few symptoms and function better than historical controls
who had surgical treatment of chronic pancreatitis.
DISCUSSION
Heretofore, prophylactic splenectomy to prevent gastric
variceal hemorrhage has been recommended for patients with
splenic vein thrombosis, but the benefit of splenectomy was
difficult to determine because the natural history of was
relatively unknown. Previous studies may have overestimated
the frequency of gastric variceal hemorrhage due, in part, to
limited diagnostic tools and etiologic heterogeneity. There-
fore, our aim was to determine the natural history of pancre-
atitis-induced splenic vein thrombosis with a specific interest
in the frequency of gastric variceal hemorrhage. Our data
demonstrate that observation of patients with pancreatitis-
induced splenic vein thrombosis is associated with an overall
incidence of gastric variceal hemorrhage of approximately
4%, with no deaths secondary to variceal bleeding. Varices
demonstrated on CT were associated with a 5% risk of
bleeding, but the presence of varices on endoscopy increased
this risk nearly 4-fold. Of all cases of upper gastrointestinal
bleeding in this series, less than half were secondary to
bleeding gastric varices, emphasizing the need for a thorough
evaluation of bleeding in patients with splenic vein thrombo-
sis. Additionally, this study shows that observation of splenic
vein thrombosis does not negatively affect quality of life
compared with reported series of patients undergoing surgical
treatment of chronic pancreatitis.
TABLE 3. Detection of Varices
Modality n (%) Varices Present (%) Variceal Hemorrhage* Percent Variceal Hemorrhage
Total (any modality) 53 (100) 41 (77.4) 2 (3.8) 4.9%
CT 53 (100) 40 (75.5) 2 (3.8) 5.0%
EGD 36 (67.9) 11 (30.6) 2 (5.6) 18.2%†
Both CT & EGD 36 (67.9) 10 (27.8) 2 (5.6) 20%‡
*No patient without varices on CT or EGD bled.
†P  0.07 vs. CT;
‡P  0.06 vs. CT.
TABLE 2. Radiographic Findings
n (%)
(n  53)
Splenic vein thrombosis 22 (41.5)
Splenic vein nonvisualization 31 (58.5)
Extent of thrombosis
Splenic vein only 34 (64.3)
Splenic and superior mesenteric vein 10 (18.7)
Splenic and portal vein 3 (5.7)
Splenic, superior mesenteric, and portal vein 6 (11.3)
Pseudocyst 47 (88.7)
Gastrosplenic varices 41 (77.4)
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Previous studies have addressed the management of
splenic vein thrombosis by characterizing its natural history.
Earlier reports relied almost exclusively on celiac angiogra-
phy or splenoportography for the diagnosis of splenic vein
thrombosis,6,9,12–14 and the frequency of gastrointestinal
bleeding in these studies8,12–14 ranged from 37 to 100%.
Thus, early data suggested that variceal bleeding was a
frequent if not unavoidable sequela of splenic vein thrombo-
sis. A 1985 review by Moosa and Gadd2 found that nearly
half of all patients with splenic vein thrombosis, and 70% of
those with gastroesophageal varices, presented with bleeding.
Such high rates of bleeding prompted several authors2,6 to
recommend routine splenectomy. Though clearly demonstrat-
ing that potentially fatal complications do occur in patients
with splenic vein thrombosis, these studies were limited in
recognizing minimally symptomatic patients with splenic
vein thrombosis because angiography was not routinely em-
ployed in patients without severe symptoms. Consequently, a
disproportionately high percentage of patients presented with
variceal bleeding; therefore, nearly all patients underwent
splenectomy.
Recent studies have focused on the role of expectant
management for patients with asymptomatic splenic vein
thrombosis. In their series of 37 patients, Loftus et al5
recommended observation for those with asymptomatic sin-
istral portal hypertension. Though 54% of their patients were
diagnosed with splenic vein thrombosis by celiac angiogra-
phy or splenoportography, half were evaluated, at least in
part, by CT. Findings from this study highlighted the utility of
CT in splenic vein thrombosis and its important role in the
diagnosis and management of pancreatic disease. Despite
these diagnostic advances, however, two thirds of their pa-
tients presented with variceal bleeding, thereby necessitating
splenectomy. Thus only 12 remaining patients were available
for evaluation of the natural history of splenic vein thrombo-
sis. Similarly, Sakorafas et al3 studied splenic vein thrombo-
sis diagnosed by CT in 34 patients, of whom only 5 presented
with variceal bleeding. Though diagnostic improvements
likely explain the decrease in variceal bleeding seen at pre-
sentation in this study, only 11 patients did not undergo
splenectomy, again limiting the number of patients undergo-
ing nonoperative management of splenic vein thrombosis. No
patient in this study initially presented with variceal bleeding,
further confirming the sensitivity of CT to detect abnormal-
ities in the splenic vasculature. Also, 26 patients had no
operative treatment of pancreatitis, and only 2 (4%) patients




Operative treatment 21 (39.6)
Necrosectomy 7 (13.2)
External drainage of pseudocyst 2 (3.8)
Puestow procedure 3 (5.7)
Cystenterostomy 4 (7.5)
Distal pancreatectomy and splenectomy 3 (5.7)
Splenectomy 2 (3.8)
Percutaneous pseudocyst drainage 6 (11.3)
TABLE 5. Complications of Management
n (%)
(n  53)
Upper GI bleeding 5 (9.4)
Gastric varices 2 (3.8)
Other causes 3 (5.7)
Gastritis 1 (1.9)
Gastric cancer 1 (1.9)




Substance abuse 2 (3.8)
Cancer 1 (1.9)
Myocardial infarction 1 (1.9)
TABLE 6. Functional Outcome
Median (range) Historical10
Functional scales
Physical status 100 (0–100) 70 (20–100)
Working ability 100 (0–100) 50 (0–100)
Cognitive 100 (50–100) 66.7 (40–100)
Emotional 100 (8.25–100) 66.7 (40–100)
Social 100 (0–100) 66.7 (0–100)
Global quality of life 66.6 (25–100) 57.1 (33.3–100)
Symptom scales
Fatigue 89 (44.3–100) 66.7 (33.3–100)
Nausea and vomiting 100 (83.5–100) 100 (33.3–100)
Pain 83.5 (33–100) 100 (80–100)
Loss of appetite 100 (33–100) 100 (50–100)
Dyspnea 100 (67–100) 100 (66.7–100)
Sleep disturbance 100 (0–100) 83.3 (33.3–100)
Constipation 100 (33–100) 66.7 (33.3–100)
Diarrhea 100 (67–100) 100 (33.3–100)
Financial strain 100 (33–100) 100 (66.7–100)
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experienced bleeding from gastric varices, suggesting that,
indeed, the risk of bleeding from pancreatitis-induced splenic
vein thrombosis is low.
Advances in diagnostic radiology aside, heterogeneity
in the disease processes causing splenic vein thrombosis may
contribute to the differences between this and previous stud-
ies. In acute pancreatitis, splenic vein thrombosis is fre-
quently initiated by local, pro-thrombotic, inflammatory
changes in the vascular endothelium, extrinsic splenic vein
compression by pseudocysts, relatively low pancreatic perfu-
sion, or later in the course of disease pancreatic fibrosis.
Unlike other causes of splenic vein thrombosis, such as
malignancy, or hypercoagulable states, the factors responsi-
ble for pancreatitis-induced splenic vein thrombosis are often
transient. Therefore, the natural history of pancreatitis-in-
duced splenic vein thrombosis may differ from that which
results from other etiologies. In the report by Loftus et al,5
only 15 of 37 patients had splenic vein thrombosis secondary
to pancreatitis, including only 4 of the 12 who were observed.
Sakorafas et al3 presented 34 patients with splenic vein
thrombosis secondary to pancreatitis with 50% of those
experiencing gastrointestinal bleeding and two thirds ulti-
mately requiring splenectomy. Importantly, however, those
patients were surgically selected and may not adequately
represent all patients with pancreatitis-induced splenic vein
thrombosis. In our series, only 2 of 40 patients with varices
detected by CT and 2 of 11 patients with endoscopically
detected varices experienced bleeding. No episodes of bleed-
ing occurred in the absence of varices or in patients with
varices on CT but a normal EGD. Another recent study
routinely screening patients with pancreatitis for visceral
thrombosis found that only 1 of 6 patients with endoscopi-
cally demonstrated gastroesophageal varices bled, supporting
our finding that the incidence of variceal bleeding is low.15
Improvements in diagnostic radiology have allowed a
more complete understanding of the natural history of splenic
vein thrombosis in the setting of pancreatitis. Routine sple-
nectomy for pancreatitis-induced splenic vein thrombosis is
not indicated given the low incidence of gastric variceal
hemorrhage (4%) and the absence of mortality related to
variceal hemorrhage. Patients with endoscopically demon-
strated gastric varices had a higher incidence of bleeding
(18%) and should be educated about the risks of bleeding and
the potential need for urgent intervention. Patients with
splenic vein thrombosis, particularly with varices seen on CT
should undergo regular upper gastrointestinal endoscopy with
splenectomy reserved for those who experience bleeding or
have an increased risk of hemorrhage. Upper gastrointestinal
hemorrhage should be evaluated thoroughly in patients with
splenic vein thrombosis because nonvariceal bleeding is as
common as bleeding from gastric varices.
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Discussions
DR. WILLIAM H. NEALON (GALVESTON, TEXAS): I would
like to congratulate the authors for shedding some light on a
subject which is infrequently examined as a complication of
pancreatitis. I appreciate the authors providing me the manu-
script in a timely fashion. I particularly admire the paper
because it confirms my bias.
Dr. Behrns and his colleagues have evaluated 53 pa-
tients with sinistral portal hypertension and gastric varices.
Two of these patients sustained an episode of variceal bleed-
ing necessitating splenectomy. The existing literature on this
subject, some recent and some prior to the ready availability
of cross-sectional imaging, have warned of a 40 to 70%
chance of bleeding from this problem. In my experience with
more than 300 patients with chronic pancreatitis followed
longitudinally, many of whom have had splenic or portal vein
thrombosis, I have seen no cases of variceal hemorrhage. One
of the 2 patients who bled in this series did so as a compli-
cation of excessive anticoagulation.
The study is retrospective, which has well-established
flaws. Twenty-five percent had a history of acute pancreatitis,
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and 75% had chronic pancreatitis. Nearly 90% had pseudo-
cysts, more than half of which were managed operatively or
with percutaneous drainage. Quality-of-life interviews were
completed on 29 of 46 surviving patients, and remarkably
their quality-of-life levels were superior to standard chronic
pancreatitis patients. Patients who had EGD were more likely
to bleed.
I have a few questions. I have performed splenectomy
for severe left-sided abdominal pain. Were you able to de-
termine that any of these patients had this classic pattern of
pain?
I am interested by the preponderance of pseudocysts in
your series. We certainly see numerous patients with chronic
pancreatitis and splenic vein thrombosis without pseudocyst.
Can you comment on this high frequency of pseudocyst?
Did pseudocyst drainage affect the varices in any of
these patients?
Why would this group’s quality of life be superior to
most large series of chronic pancreatitis patients? Is it possi-
ble that the patients with acute pancreatitis have skewed the
data?
Finally, the death rate of 13% seems high. Nearly half
of deaths were attributable to sepsis. Do you know if any of
these were post-splenectomy sepsis? And could this possibly
be another deterrent to readily performing splenectomy on
these patients?
DR. ATTILA NAKEEB (INDIANAPOLIS, INDIANA): Dr. Behrns
and his colleagues from the University of North Carolina
nicely characterized the natural history and risks of gastro-
esophageal hemorrhage in patients with splenic vein throm-
bosis secondary to pancreatitis. In the Midwest, we also don’t
see gastroesophageal bleeding secondary to splenic vein
thrombosis in our patients with pancreatitis. It is clear with
the recent use of cross-sectional imaging, especially CT
scanning, in many of our patients with pancreatitis that we are
identifying these patients while they are asymptomatic.
In the current study, the authors have identified 53
patients with splenic vein thrombosis and pancreatitis over a
10-year period. Three quarters of these patients were male
and had a diagnosis of chronic pancreatitis, and almost 90%
of the patients had an associated pancreatic pseudocyst.
Gastric splenic varices were identified in three quarters of
their patients on CT scanning. Of the patients who underwent
endoscopy, approximately 30% had identified varices. In
their follow-up at a mean of 40 months, the risk of variceal
bleeding was only 5% in patients with varices identified on
CT and 4 times as great in the patients with varices seen on
EGD. Only 4% of their patients required a splenectomy for
bleeding.
I have several questions for the authors. Can you tell us
how common splenic vein thrombosis is in your patients with
pancreatitis? What is the denominator of your study?
Second, is the etiology of pancreatitis related to the
splenic vein thrombosis. Is it more common in your patients
with alcoholic pancreatitis, and does continued alcohol abuse
have any effect on either quality of life or the bleeding?
Third, as you currently recommend EGD for all pa-
tients with splenic vein thrombosis seen on CT scanning,
have you used or do you have any experience using beta-
blockers in these patients with varices identified to try to
minimize venous hypertension and the risk of bleeding?
Fourth, since almost 40% of your patients underwent
operative intervention, does the presence of splenic vein
thrombosis alter your operative management in any way? Are
you more likely to perform a resection and splenectomy for a
pseudocyst as opposed to doing an enteric drainage in these
patients?
DR. LAYTON F. RIKKERS (MADISON, WISCONSIN): I would
like to congratulate Dr. Behrns and his group on an excellent
study, which I think confirms what other past series have
shown, namely that splenic vein thrombosis is not frequently
complicated by variceal bleeding.
My first question is in regards to the diagnosis itself.
Many of the patients were diagnosed with splenic vein
thrombosis by not seeing the splenic vein on the CT scan and
no collaterals being identified. If these were retrospective
examinations of CT scans, I am not certain that all of those
patients had splenic vein thrombosis. Usually we like to see
the absence of the splenic vein plus some collaterals to make
the diagnosis of splenic vein thrombosis.
I have had the opportunity to take care of a large group
of patients over a long period of time who have bled from
varices from extrahepatic portal hypertension, with splenic
vein thrombosis, portal vein thrombosis, superior mesenteric
vein thrombosis, or combinations of those entities. Most of
these patients had a hypercoagulable syndrome. These pa-
tients tend to bleed from varices, whereas those with splenic
vein thrombosis or portal vein thrombosis secondary to pan-
creatitis seem to be less likely to bleed. Do you have any
thoughts on this?
The most difficult complication with which these pa-
tients can present is small bowel variceal bleeding. This tends
to occur in patients with superior mesenteric vein thrombosis.
It is virtually impossible to identify the site of bleeding, these
patients cannot be shunted, and they are very difficult to
manage.
If you are operating in the abdomen in a patient with a
known splenic vein thrombosis for some other reason, would
you take out the spleen while you were there?
Finally, since thrombosis is a much more life-threaten-
ing complication in general than bleeding, is there any role
for long-term anticoagulation of these patients?
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DR. T. RYAN HEIDER (CHAPEL HILL, NORTH CAROLINA):
Dr. Nealon asked about the clinical syndrome of left-sided
abdominal pain. In this series, we did not see any patients
presenting with that clinical syndrome; of all patients that
were interviewed, none reported its development.
With regard to the frequency of pseudocysts in the
series, nearly 90% of our patients had pseudocysts, which is
higher than the rates of 50% to 60% reported in the literature.
Many of the pseudocysts in our series were small, clinically
insignificant pseudocysts that probably would have been
undetected in older series but were included for the sake of
data completeness. Although higher than previous reports,
this may simply reflect improved detection rather than a true
difference between study populations.
With regard to whether the drainage of pseudocysts
affects the course of splenic vein thrombosis, I certainly think
it could play a role. Although a retrospective study, we
observed perhaps 10 to 15 patients who underwent serial
CTs; in 3 or 4 patients, there was documented resolution of
their splenic vein thrombosis after treatment of their pseudo-
cyst, whether operatively or through percutaneous drainage.
Additionally, 1 patient’s splenic vein thrombosis resolved
simply after the resolution of the pancreatitis. It certainly
appears that pseudocysts could be a contributing etiologic
factor and that addressing them may encourage the resolution
of splenic vein thrombosis.
With regard to sepsis, both patients in our series un-
dergoing splenectomy were alive without complication. Of
the cases of sepsis in this series, 1 was due to fulminant
necrotizing pancreatitis; the other 2 were unrelated to their
pancreatic disease. There were no documented cases of post-
splenectomy sepsis, but certainly this is a consideration when
deciding whether to perform splenectomy.
Dr. Nakeeb asked several questions, the first regarding
the denominator of the study or our incidence of splenic vein
thrombosis. We queried 3 different databases, acute pancre-
atitis, chronic pancreatitis as well as pseudocysts, though
there was significant overlap in these databases. Knowing
from the literature that the incidence of splenic vein throm-
bosis would most likely be highest in the pseudocyst group,
we queried them first, and out of 250 patients drew most of
the cases of splenic vein thrombosis. To make sure we
weren’t missing a large population of cases of splenic vein
thrombosis in the other categories, however, we queried 100
of several thousand entries in the acute and chronic pancre-
atitis, only picking up 1 or 2 additional cases. The overall
denominator was 450, so roughly a 12% incidence of splenic
vein thrombosis.
In response to your question regarding any potential
differences between alcoholic and gallstone pancreatitis, we
didn’t notice any differences, though that may be just due to
small numbers. Nearly 60% of our patients had alcohol-
induced pancreatitis, but we weren’t able to discern any
differences based on etiology of pancreatitis.
The medical management of their portal hypertension,
intraoperatively and postoperatively, is something we have
not done. That is an interesting idea that we will likely
employ in the future.
With regard to your question regarding splenectomy
concomitant with other pancreatic operations, as well as Dr.
Rikkers’ question regarding performing splenectomy during
the course of other abdominal operations, I think we would
go ahead and perform a splenectomy if the planned operation
included a distal pancreatic resection. But we would not
choose to perform an alternate pancreatic operation that we
felt was less than ideal solely for the purpose of removing the
spleen at the same time. For non-pancreatic abdominal oper-
ations, we would not perform a splenectomy.
Dr. Rikkers asked about our diagnosis of splenic vein
thrombosis with regard to nonvisualization on CT. We looked
exhaustively for secondary evidence of splenic vein throm-
bosis in these patients. Additionally, we talked with radiolo-
gists and felt that if you obtained a good quality CT scan with
the appropriate venous contrast phase in the setting of pan-
creatitis, that there was likely splenic vein thrombosis in these
cases. However, the majority of patients with nonvisualiza-
tion either had varices seen by CT or the suggestion of splenic
vein thrombosis by ultrasound, MRI, or another modality. In
the absence of secondary findings, however, splenic vein
nonvisualization may not be absolutely equivalent as visual-
ized splenic vein thrombosis.
We were fortunate not to see any cases of variceal
bleeding through the SMV or IMV circulation into the bowel.
We certainly understand from the literature that is a difficult
problem; unfortunately, we don’t have any advice to offer for
that particular complication.
Of the 2 patients who bled in our series, 1 was antico-
agulated for cardiac reasons, which exacerbated and perhaps
precipitated his variceal bleeding. So I think what we know
about the natural history from our data, we would not anti-
coagulate these patients, but rather treat the underlying pan-
creatitis and/or pseudocysts and await spontaneous resolution
of their splenic vein thrombosis.
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